1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Canakinumab for the Treatment of Postprandial HypoglycemiaNutritional and Metabolic Diseases, Postprandial Hypoglycemia, glucose metabolism disease, hypoglycemia, metabolic diseaseRecruitingPhase 32025-01-29NCT05401578